SECONDARY HYPERPARATHYROIDISM
Clinical trials for SECONDARY HYPERPARATHYROIDISM explained in plain language.
Never miss a new study
Get alerted when new SECONDARY HYPERPARATHYROIDISM trials appear
Sign up with your email to follow new studies for SECONDARY HYPERPARATHYROIDISM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for dialysis Patients' hormone imbalance
Disease control CompletedThis study tested whether a new drug called SHR6508 could safely and effectively treat a serious hormone imbalance (secondary hyperparathyroidism) in people with kidney failure who are on regular dialysis. It involved 498 participants in China and compared the drug's effects to a…
Matched conditions: SECONDARY HYPERPARATHYROIDISM
Phase: PHASE3 • Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New hope for dialysis patients with dangerous hormone imbalance
Disease control CompletedThis study tested a drug called PLS240 for people with kidney failure on dialysis who also have a serious hormone disorder called secondary hyperparathyroidism. In the first part, 362 participants were randomly assigned to receive either the real drug or a placebo for 27 weeks. A…
Matched conditions: SECONDARY HYPERPARATHYROIDISM
Phase: PHASE3 • Sponsor: Pathalys Pharma • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope for dialysis patients with dangerous hormone imbalance
Disease control CompletedThis study tested a drug called PLS240 for people with kidney failure on dialysis who also have a serious hormone problem called secondary hyperparathyroidism. For the first 27 weeks, 412 participants were randomly assigned to receive either the real drug or a placebo (inactive s…
Matched conditions: SECONDARY HYPERPARATHYROIDISM
Phase: PHASE3 • Sponsor: Pathalys Pharma • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC